Dr. Leelatian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
C-2318 MCN
1211 Medical Center Dr
Nashville, TN 37232- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Neuropathology, 2021 - 2023
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2018 - 2021
- Vanderbilt UniversityPhD, Cancer Biology, 2012 - 2018
- Siriraj Medical School/Mahidol UniversityClass of 2009
Certifications & Licensure
- TN State Medical License 2021 - 2025
- NC State Medical License 2023 - 2024
- CT State Medical License 2018 - 2022
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 8 citationsThe Role of Mismatch Repair in Glioblastoma Multiforme Treatment Response and Resistance.Nalin Leelatian, Christopher S. Hong, Ranjit S. Bindra
Neurosurgery Clinics of North America. 2021-02-18 - 10 citationsLocation-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesisGabrielle V. Rushing, Asa A. Brockman, Madelyn K Bollig, Nalin Leelatian, Bret C. Mobley
Life Science Alliance. 2019-04-01 - 16 citationsTumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity.Sophia Gayle, Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold
NAR Cancer. 2021-04-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: